Clinical Trial Update: Varenicline for Smoking Reduction in Veterans Not Ready To Quit [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for varenicline aimed at reducing smoking in veterans not ready to quit; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (Chantix) (varenicline)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Veterans, Tobacco Use Disorder | Phase 4 | Status: NOT_YET_RECRUITING